YASIR O BABIKER

Allopathic & Osteopathic Physicians|Internal Medicine BAD AXE, MI NPI 1861685307

General Payments — all program years on this page

$674.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $297.04 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $297.0417

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $12.081
2019 $28.082
2020 $17.581
2021 $13.361
2022 $34.272
2023 $271.6216
2024 $297.0417

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096701558 Novo Nordisk Inc $14.74 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096950644 Novo Nordisk Inc $20.60 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097337447 Novo Nordisk Inc $13.46 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097543702 Novo Nordisk Inc $19.70 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097557686 Novo Nordisk Inc $18.19 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097713046 Novo Nordisk Inc $15.31 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097765301 Novo Nordisk Inc $16.40 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103259227 ABBVIE INC. $21.02 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114582309 Exact Sciences Corporation $13.72 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114582312 Exact Sciences Corporation $14.54 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116279444 GlaxoSmithKline, LLC. $18.57 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116473117 GlaxoSmithKline, LLC. $14.17 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118196406 Boehringer Ingelheim Pharmaceuticals, Inc. $17.24 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131392362 PFIZER INC. $15.66 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135486862 Lilly USA, LLC $16.51 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135518758 Lilly USA, LLC $23.42 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144617833 Xeris Pharmaceuticals, Inc. $23.79 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.